Ambalal Sarabhai Enterprises Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 12, 2025, 9:34 am

Market Cap	284 Cr.
Current Price	37.0
High / Low	77.7/35.1
Stock P/E	20.0
Book Value	18.3
Dividend Yield	0.00 %
ROCE	7.08 %
ROE	4.22 %
Face Value	10.0
PEG Ratio	-1.49

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Ambalal Sarabhai Enterprises Ltd

Competitors of Ambalal Sarabhai Enterprises Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
MPS Pharmaa Ltd	6.71 Cr.	3.51	4.33/3.05		0.80	0.00 %	9.15 %	34.9 %	10.0
Gujarat Themis Biosyn Ltd	2,663 Cr.	244	390/192	50.6	20.5	0.27 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	53.1 Cr.	71.5	94.9/32.1	18.0	11.9	0.00 %	9.72 %	3.44 %	10.0
Gujarat Inject (Kerala) Ltd	38.0 Cr.	26.0	29.0/8.74	38.8	6.64	0.00 %	2.65 %	2.08 %	10.0
Godavari Drugs Ltd	70.4 Cr.	93.5	155/79.0	11.4	55.4	0.00 %	14.4 %	15.5 %	10.0
Industry Average	17,255.37 Cr	1,081.84		42.42	185.80	0.37%	16.00%	16.32%	6.27

All Competitor Stocks of Ambalal Sarabhai Enterprises Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	43.10	54.43	43.65	46.84	35.36	44.44	36.10	40.01	43.11	54.35	40.70	44.70	45.97
Expenses	37.15	53.09	42.91	46.11	33.79	41.09	40.07	39.00	40.58	49.70	40.23	42.16	46.67
Operating Profit	5.95	1.34	0.74	0.73	1.57	3.35	-3.97	1.01	2.53	4.65	0.47	2.54	-0.70
OPM %	13.81%	2.46%	1.70%	1.56%	4.44%	7.54%	-11.00%	2.52%	5.87%	8.56%	1.15%	5.68%	-1.52%
Other Income	0.65	8.54	2.69	2.38	3.06	5.71	1.37	2.85	1.63	4.79	2.30	2.80	5.76
Interest	0.33	0.45	0.43	0.45	0.56	0.99	0.95	0.92	0.99	0.90	0.95	1.22	1.14
Depreciation	0.58	0.62	0.60	0.62	0.61	0.92	1.05	1.14	1.13	0.25	0.98	1.01	0.99
Profit before tax	5.69	8.81	2.40	2.04	3.46	7.15	-4.60	1.80	2.04	8.29	0.84	3.11	2.93
Tax %	38.49%	13.96%	34.17%	50.00%	12.72%	20.14%	5.87%	40.00%	34.31%	-8.69%	59.52%	15.76%	23.89%
Net Profit	3.50	7.59	1.58	1.02	3.01	5.71	-4.87	1.08	1.33	9.02	0.35	2.62	2.23
EPS in Rs	0.46	0.99	0.21	0.13	0.39	0.75	-0.64	0.14	0.17	1.18	0.05	0.34	0.29

Last Updated: February 28, 2025, 3:40 pm

Below is a detailed analysis of the quarterly data for Ambalal Sarabhai Enterprises Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹45.97 Cr.. The value appears strong and on an upward trend. It has increased from 44.70 Cr. (Sep 2024) to ₹45.97 Cr., marking an increase of ₹1.27 Cr..
For Expenses, as of Dec 2024, the value is ₹46.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 42.16 Cr. (Sep 2024) to ₹46.67 Cr., marking an increase of ₹4.51 Cr..
For Operating Profit, as of Dec 2024, the value is ₹-0.70 Cr.. The value appears to be declining and may need further review. It has decreased from 2.54 Cr. (Sep 2024) to ₹-0.70 Cr., marking a decrease of 3.24 Cr..
For OPM %, as of Dec 2024, the value is -1.52%. The value appears to be declining and may need further review. It has decreased from 5.68% (Sep 2024) to -1.52%, marking a decrease of 7.20%.
For Other Income, as of Dec 2024, the value is ₹5.76 Cr.. The value appears strong and on an upward trend. It has increased from 2.80 Cr. (Sep 2024) to ₹5.76 Cr., marking an increase of ₹2.96 Cr..
For Interest, as of Dec 2024, the value is ₹1.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.22 Cr. (Sep 2024) to ₹1.14 Cr., marking a decrease of 0.08 Cr..
For Depreciation, as of Dec 2024, the value is ₹0.99 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.01 Cr. (Sep 2024) to ₹0.99 Cr., marking a decrease of 0.02 Cr..
For Profit before tax, as of Dec 2024, the value is ₹2.93 Cr.. The value appears to be declining and may need further review. It has decreased from 3.11 Cr. (Sep 2024) to ₹2.93 Cr., marking a decrease of 0.18 Cr..
For Tax %, as of Dec 2024, the value is 23.89%. The value appears to be increasing, which may not be favorable. It has increased from 15.76% (Sep 2024) to 23.89%, marking an increase of 8.13%.
For Net Profit, as of Dec 2024, the value is ₹2.23 Cr.. The value appears to be declining and may need further review. It has decreased from 2.62 Cr. (Sep 2024) to ₹2.23 Cr., marking a decrease of 0.39 Cr..
For EPS in Rs, as of Dec 2024, the value is 0.29. The value appears to be declining and may need further review. It has decreased from ₹0.34 (Sep 2024) to 0.29, marking a decrease of ₹0.05.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:07 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	100	105	124	132	134	125	150	133	163	197	170	173	186
Expenses	111	112	129	145	137	137	144	136	165	171	162	167	179
Operating Profit	-10	-7	-4	-13	-3	-12	6	-3	-2	25	8	6	7
OPM %	-10%	-7%	-3%	-10%	-2%	-9%	4%	-2%	-1%	13%	5%	3%	4%
Other Income	16	2	13	95	-2	25	8	24	40	33	12	10	16
Interest	9	11	10	4	5	3	3	4	3	2	3	6	4
Depreciation	14	3	5	17	4	2	2	3	2	2	3	4	3
Profit before tax	-16	-20	-6	62	-14	8	8	15	33	54	15	7	15
Tax %	11%	3%	13%	22%	34%	84%	48%	6%	10%	13%	25%	15%
Net Profit	-18	-20	-7	48	-18	1	4	14	29	47	11	6	14
EPS in Rs	-2.39	-2.64	-0.87	6.28	-2.38	0.17	0.55	1.83	3.83	6.16	1.49	0.74	1.86
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-11.11%	65.00%	785.71%	-137.50%	105.56%	300.00%	250.00%	107.14%	62.07%	-76.60%	-45.45%
Change in YoY Net Profit Growth (%)	0.00%	76.11%	720.71%	-923.21%	243.06%	194.44%	-50.00%	-142.86%	-45.07%	-138.66%	31.14%

Ambalal Sarabhai Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

No data available for the compounded sales growth chart.

Balance Sheet

Last Updated: December 14, 2024, 2:18 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	77	77	77	77	77	77	77	77	77	77	77	77	77
Reserves	-59	-79	-86	-38	-51	-50	-46	-32	-3	43	54	60	64
Borrowings	39	42	46	47	42	43	40	31	28	27	45	46	51
Other Liabilities	110	128	132	94	93	128	144	111	108	84	70	67	69
Total Liabilities	167	167	169	180	160	197	214	186	210	231	246	250	260
Fixed Assets	98	94	91	72	72	59	58	57	57	58	85	88	89
CWIP	0	0	1	9	3	14	24	0	1	12	4	0	0
Investments	1	1	1	8	5	5	9	18	27	33	32	30	32
Other Assets	67	71	76	92	80	119	123	110	125	128	125	133	139
Total Assets	167	167	169	180	160	197	214	186	210	231	246	250	260

Below is a detailed analysis of the balance sheet data for Ambalal Sarabhai Enterprises Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹77.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹77.00 Cr..
For Reserves, as of Sep 2024, the value is ₹64.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹60.00 Cr. (Mar 2024) to ₹64.00 Cr., marking an increase of 4.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹51.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹46.00 Cr. (Mar 2024) to ₹51.00 Cr., marking an increase of 5.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹69.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹67.00 Cr. (Mar 2024) to ₹69.00 Cr., marking an increase of 2.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹260.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹250.00 Cr. (Mar 2024) to ₹260.00 Cr., marking an increase of 10.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹89.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹88.00 Cr. (Mar 2024) to ₹89.00 Cr., marking an increase of 1.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Investments, as of Sep 2024, the value is ₹32.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹30.00 Cr. (Mar 2024) to ₹32.00 Cr., marking an increase of 2.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹139.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹133.00 Cr. (Mar 2024) to ₹139.00 Cr., marking an increase of 6.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹260.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹250.00 Cr. (Mar 2024) to ₹260.00 Cr., marking an increase of 10.00 Cr..

Notably, the Reserves (₹64.00 Cr.) exceed the Borrowings (51.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-3	11	-8	-75	5	-7	19	-7	-2	11	6	5
Cash from Investing Activity +	-0	-1	10	80	-3	18	-9	17	10	5	-17	-1
Cash from Financing Activity +	3	-8	-1	-3	-6	-2	-6	-14	-6	-19	9	-3
Net Cash Flow	-1	2	1	2	-4	8	3	-4	2	-3	-2	1

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-49.00	-49.00	-50.00	-60.00	-45.00	-55.00	-34.00	-34.00	-30.00	-2.00	-37.00	-40.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	101	95	74	83	79	100	84	79	87	52	59	55
Inventory Days	92	95	86	72	66	75	61	76	58	48	62	58
Days Payable	142	178	139	135	138	207	191	184	184	151	131	133
Cash Conversion Cycle	51	12	22	20	6	-32	-46	-29	-39	-50	-10	-19
Working Capital Days	-161	-219	-204	-47	-89	-98	-120	-74	-37	18	30	41
ROCE %	-14%	-16%	-19%	-44%	-1%	-5%	16%	25%	18%	34%	11%	7%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	30.76%	30.76%	30.76%	30.77%	30.77%	30.78%	30.78%	30.78%	30.78%	30.78%	31.35%	31.35%
DIIs	0.01%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.10%
Public	69.24%	69.24%	69.23%	69.23%	69.22%	69.22%	69.23%	69.21%	69.23%	69.22%	68.65%	68.54%
No. of Shareholders	1,81,213	1,81,589	1,80,199	1,79,404	1,78,274	1,77,743	1,75,222	1,71,944	1,70,079	1,69,228	1,72,338	1,71,221

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.74	1.45	6.16	3.83	1.83
Diluted EPS (Rs.)	0.74	1.45	6.16	3.83	1.83
Cash EPS (Rs.)	1.56	1.94	5.63	2.96	2.35
Book Value[Excl.RevalReserv]/Share (Rs.)	17.90	17.09	15.64	9.64	5.84
Book Value[Incl.RevalReserv]/Share (Rs.)	17.90	17.09	15.64	9.64	5.84
Revenue From Operations / Share (Rs.)	22.65	22.22	25.67	21.35	17.42
PBDIT / Share (Rs.)	2.18	2.75	8.73	3.76	2.90
PBIT / Share (Rs.)	1.71	2.39	8.43	3.44	2.56
PBT / Share (Rs.)	1.22	2.07	6.23	3.06	2.13
Net Profit / Share (Rs.)	1.10	1.58	5.32	2.64	2.01
NP After MI And SOA / Share (Rs.)	0.74	1.45	6.16	3.83	1.83
PBDIT Margin (%)	9.61	12.36	34.00	17.59	16.62
PBIT Margin (%)	7.55	10.74	32.82	16.11	14.70
PBT Margin (%)	5.39	9.31	24.28	14.31	12.21
Net Profit Margin (%)	4.83	7.13	20.73	12.36	11.56
NP After MI And SOA Margin (%)	3.27	6.51	23.99	17.93	10.53
Return on Networth / Equity (%)	4.14	8.47	39.39	39.72	31.41
Return on Capital Employeed (%)	8.86	12.15	51.65	32.36	37.05
Return On Assets (%)	2.27	4.51	20.48	13.97	7.54
Long Term Debt / Equity (X)	0.06	0.13	0.02	0.07	0.10
Total Debt / Equity (X)	0.32	0.30	0.21	0.35	0.63
Asset Turnover Ratio (%)	0.69	0.71	0.00	0.00	0.00
Current Ratio (X)	1.16	1.23	1.14	0.93	0.77
Quick Ratio (X)	1.00	1.04	0.99	0.81	0.65
Inventory Turnover Ratio (X)	0.90	0.80	0.00	0.00	0.00
Interest Coverage Ratio (X)	4.44	8.64	39.34	9.76	6.68
Interest Coverage Ratio (Post Tax) (X)	3.23	5.98	33.88	7.86	5.65
Enterprise Value (Cr.)	360.72	169.24	264.81	129.80	152.65
EV / Net Operating Revenue (X)	2.08	0.99	1.35	0.79	1.14
EV / EBITDA (X)	21.61	8.04	3.96	4.51	6.88
MarketCap / Net Operating Revenue (X)	2.01	0.92	1.36	0.82	1.09
Price / BV (X)	2.54	1.20	2.23	1.83	3.26
Price / Net Operating Revenue (X)	2.01	0.92	1.36	0.82	1.09
EarningsYield	0.01	0.07	0.17	0.21	0.09

After reviewing the key financial ratios for Ambalal Sarabhai Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 0.74. This value is below the healthy minimum of 5. It has decreased from 1.45 (Mar 23) to 0.74, marking a decrease of 0.71.
For Diluted EPS (Rs.), as of Mar 24, the value is 0.74. This value is below the healthy minimum of 5. It has decreased from 1.45 (Mar 23) to 0.74, marking a decrease of 0.71.
For Cash EPS (Rs.), as of Mar 24, the value is 1.56. This value is below the healthy minimum of 3. It has decreased from 1.94 (Mar 23) to 1.56, marking a decrease of 0.38.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 17.90. It has increased from 17.09 (Mar 23) to 17.90, marking an increase of 0.81.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 17.90. It has increased from 17.09 (Mar 23) to 17.90, marking an increase of 0.81.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 22.65. It has increased from 22.22 (Mar 23) to 22.65, marking an increase of 0.43.
For PBDIT / Share (Rs.), as of Mar 24, the value is 2.18. This value is within the healthy range. It has decreased from 2.75 (Mar 23) to 2.18, marking a decrease of 0.57.
For PBIT / Share (Rs.), as of Mar 24, the value is 1.71. This value is within the healthy range. It has decreased from 2.39 (Mar 23) to 1.71, marking a decrease of 0.68.
For PBT / Share (Rs.), as of Mar 24, the value is 1.22. This value is within the healthy range. It has decreased from 2.07 (Mar 23) to 1.22, marking a decrease of 0.85.
For Net Profit / Share (Rs.), as of Mar 24, the value is 1.10. This value is below the healthy minimum of 2. It has decreased from 1.58 (Mar 23) to 1.10, marking a decrease of 0.48.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.74. This value is below the healthy minimum of 2. It has decreased from 1.45 (Mar 23) to 0.74, marking a decrease of 0.71.
For PBDIT Margin (%), as of Mar 24, the value is 9.61. This value is below the healthy minimum of 10. It has decreased from 12.36 (Mar 23) to 9.61, marking a decrease of 2.75.
For PBIT Margin (%), as of Mar 24, the value is 7.55. This value is below the healthy minimum of 10. It has decreased from 10.74 (Mar 23) to 7.55, marking a decrease of 3.19.
For PBT Margin (%), as of Mar 24, the value is 5.39. This value is below the healthy minimum of 10. It has decreased from 9.31 (Mar 23) to 5.39, marking a decrease of 3.92.
For Net Profit Margin (%), as of Mar 24, the value is 4.83. This value is below the healthy minimum of 5. It has decreased from 7.13 (Mar 23) to 4.83, marking a decrease of 2.30.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.27. This value is below the healthy minimum of 8. It has decreased from 6.51 (Mar 23) to 3.27, marking a decrease of 3.24.
For Return on Networth / Equity (%), as of Mar 24, the value is 4.14. This value is below the healthy minimum of 15. It has decreased from 8.47 (Mar 23) to 4.14, marking a decrease of 4.33.
For Return on Capital Employeed (%), as of Mar 24, the value is 8.86. This value is below the healthy minimum of 10. It has decreased from 12.15 (Mar 23) to 8.86, marking a decrease of 3.29.
For Return On Assets (%), as of Mar 24, the value is 2.27. This value is below the healthy minimum of 5. It has decreased from 4.51 (Mar 23) to 2.27, marking a decrease of 2.24.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 23) to 0.06, marking a decrease of 0.07.
For Total Debt / Equity (X), as of Mar 24, the value is 0.32. This value is within the healthy range. It has increased from 0.30 (Mar 23) to 0.32, marking an increase of 0.02.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.69. It has decreased from 0.71 (Mar 23) to 0.69, marking a decrease of 0.02.
For Current Ratio (X), as of Mar 24, the value is 1.16. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 23) to 1.16, marking a decrease of 0.07.
For Quick Ratio (X), as of Mar 24, the value is 1.00. This value is within the healthy range. It has decreased from 1.04 (Mar 23) to 1.00, marking a decrease of 0.04.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.90. This value is below the healthy minimum of 4. It has increased from 0.80 (Mar 23) to 0.90, marking an increase of 0.10.
For Interest Coverage Ratio (X), as of Mar 24, the value is 4.44. This value is within the healthy range. It has decreased from 8.64 (Mar 23) to 4.44, marking a decrease of 4.20.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.23. This value is within the healthy range. It has decreased from 5.98 (Mar 23) to 3.23, marking a decrease of 2.75.
For Enterprise Value (Cr.), as of Mar 24, the value is 360.72. It has increased from 169.24 (Mar 23) to 360.72, marking an increase of 191.48.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.08. This value is within the healthy range. It has increased from 0.99 (Mar 23) to 2.08, marking an increase of 1.09.
For EV / EBITDA (X), as of Mar 24, the value is 21.61. This value exceeds the healthy maximum of 15. It has increased from 8.04 (Mar 23) to 21.61, marking an increase of 13.57.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.01. This value is within the healthy range. It has increased from 0.92 (Mar 23) to 2.01, marking an increase of 1.09.
For Price / BV (X), as of Mar 24, the value is 2.54. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 2.54, marking an increase of 1.34.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.01. This value is within the healthy range. It has increased from 0.92 (Mar 23) to 2.01, marking an increase of 1.09.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.01, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Ambalal Sarabhai Enterprises Ltd as of March 12, 2025 is: ₹12.60

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Ambalal Sarabhai Enterprises Ltd is Overvalued by 65.95% compared to the current share price 37.00

Intrinsic Value of Ambalal Sarabhai Enterprises Ltd as of March 12, 2025 is: 10.91

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Ambalal Sarabhai Enterprises Ltd is Overvalued by 70.51% compared to the current share price 37.00

Last 5 Year EPS CAGR: -13.45%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -80.00, which is a positive sign. The stock has a low average Cash Conversion Cycle of -9.50, which is a positive sign. The company has shown consistent growth in sales (145.54 cr) and profit (12.38 cr) over the years.	The stock has a low average ROCE of 1.00%, which may not be favorable. The company has higher borrowings (40.54) compared to reserves (-17.15), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambalal Sarabhai Enterprises Ltd:
1. Net Profit Margin: 4.83%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 8.86% (Industry Average ROCE: 15.87%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 4.14% (Industry Average ROE: 15.78%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 3.23
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 20 (Industry average Stock P/E: 34.01)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.32
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Ambalal Sarabhai Enterprises Ltd. is a Public Limited Listed company incorporated on 05/06/1978 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L52100GJ1978PLC003159 and registration number is 003159. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 3.81 Cr. and Equity Capital is Rs. 76.63 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	Shanti Sadan, Mirzapur Road, Ahmedabad Gujarat 380001	dsejpal@ase.life http://www.ase.life

Management
Name	Position Held
Mr. Kartikeya V Sarabhai	Executive Chairman
Mr. Mohal K Sarabhai	Managing Director
Ms. Chaula M Shastri	Whole Time Director
Dr. Pushpa Robin	Independent Director
Mr. Mayur K Swadia	Independent Director
Mr. Satyen Dave	Independent Director
Mr. Brijesh Khandelwal	Independent Director
Mr. Govindprasad Namdeo	Independent Director
Mr. Ajay Mayor	Nominee Director
Mr. Bharatendu Jani	Nominee Director

FAQ

What is the latest intrinsic value of Ambalal Sarabhai Enterprises Ltd?

The latest intrinsic value of Ambalal Sarabhai Enterprises Ltd as on 12 March 2025 is ₹12.60, which is 65.95% lower than the current market price of 37.00, indicating the stock is overvalued by 65.95%. The intrinsic value of Ambalal Sarabhai Enterprises Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹284 Cr. and recorded a high/low of ₹77.7/35.1 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹64 Cr and total liabilities of ₹260 Cr.

What is the Market Cap of Ambalal Sarabhai Enterprises Ltd?

The Market Cap of Ambalal Sarabhai Enterprises Ltd is 284 Cr..

What is the current Stock Price of Ambalal Sarabhai Enterprises Ltd as on 12 March 2025?

The current stock price of Ambalal Sarabhai Enterprises Ltd as on 12 March 2025 is ₹37.0.

What is the High / Low of Ambalal Sarabhai Enterprises Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Ambalal Sarabhai Enterprises Ltd stocks is ₹77.7/35.1.

What is the Stock P/E of Ambalal Sarabhai Enterprises Ltd?

The Stock P/E of Ambalal Sarabhai Enterprises Ltd is 20.0.

What is the Book Value of Ambalal Sarabhai Enterprises Ltd?

The Book Value of Ambalal Sarabhai Enterprises Ltd is 18.3.

What is the Dividend Yield of Ambalal Sarabhai Enterprises Ltd?

The Dividend Yield of Ambalal Sarabhai Enterprises Ltd is 0.00 %.

What is the ROCE of Ambalal Sarabhai Enterprises Ltd?

The ROCE of Ambalal Sarabhai Enterprises Ltd is 7.08 %.

What is the ROE of Ambalal Sarabhai Enterprises Ltd?

The ROE of Ambalal Sarabhai Enterprises Ltd is 4.22 %.

What is the Face Value of Ambalal Sarabhai Enterprises Ltd?

The Face Value of Ambalal Sarabhai Enterprises Ltd is 10.0.